SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-070064
Filing Date
2023-06-12
Accepted
2023-06-09 20:30:25
Documents
12
Period of Report
2023-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318406d1_8k.htm   iXBRL 8-K 32630
  Complete submission text file 0001104659-23-070064.txt   206642

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ewtx-20230609.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ewtx-20230609_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ewtx-20230609_pre.xml EX-101.PRE 22599
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2318406d1_8k_htm.xml XML 3601
Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40236 | Film No.: 231006888
SIC: 2834 Pharmaceutical Preparations